본문 바로가기
KERD
논문KCI 등재

Prognostic Implications of the Left Atrial Volume Index in Patients with Progressive Mitral Stenosis

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류내과학

초록

BACKGROUND: Limited data are available on the prognosis of progressive mitral stenosis (MS). We evaluated the factors associated with adverse events in patients with progressive MS. METHODS: We retrospectively analyzed 259 consecutive patients with pure progressive MS with a mitral valve area (MVA) between 1.5 and 2.0 cm2. The primary outcome measures were a composite endpoint of cardiac death, heart failure hospitalization, mitral valve surgery or percutaneous mitral valvuloplasty, and ischemic stroke. RESULTS: The mean patient age was 62 ± 12 years, and the mean MVA was 1.71 ± 0.15 cm2. Over a median follow-up duration of 52 months, a total of 41 patients (18.3%) experienced the composite endpoint. In multivariable Cox regression analysis, prior stroke (hazard ratio [HR], 4.54; 95% confidence interval [CI], 2.16–9.54; p < 0.001) and left atrial volume index (LAVI) of > 50 mL/m2 (HR, 4.45; 95% CI, 1.31–15.31; p = 0.017) were identified as independent predictors of the composite endpoint, even after adjusting for age and sex. Patients with a LAVI ≤ 50 mL/m2 demonstrated favorable event-free survival compared with those with a LAVI > 50 mL/m2 in either the overall population (p < 0.001) or asymptomatic patients (p = 0.002). Atrial fibrillation (AF), left ventricular mass index (LVMI), MVA, and mean diastolic pressure were factors independently associated with LAVI (all p < 0.05). CONCLUSIONS: A deleterious impact of a high LAVI on outcome was observed in patients with progressive MS. The LAVI was mainly influenced by the presence of AF, the severity of MS, and LVMI in this population.

Abstract

BACKGROUND: Limited data are available on the prognosis of progressive mitral stenosis (MS). We evaluated the factors associated with adverse events in patients with progressive MS. METHODS: We retrospectively analyzed 259 consecutive patients with pure progressive MS with a mitral valve area (MVA) between 1.5 and 2.0 cm2. The primary outcome measures were a composite endpoint of cardiac death, heart failure hospitalization, mitral valve surgery or percutaneous mitral valvuloplasty, and ischemic stroke. RESULTS: The mean patient age was 62 ± 12 years, and the mean MVA was 1.71 ± 0.15 cm2. Over a median follow-up duration of 52 months, a total of 41 patients (18.3%) experienced the composite endpoint. In multivariable Cox regression analysis, prior stroke (hazard ratio [HR], 4.54; 95% confidence interval [CI], 2.16–9.54; p < 0.001) and left atrial volume index (LAVI) of > 50 mL/m2 (HR, 4.45; 95% CI, 1.31–15.31; p = 0.017) were identified as independent predictors of the composite endpoint, even after adjusting for age and sex. Patients with a LAVI ≤ 50 mL/m2 demonstrated favorable event-free survival compared with those with a LAVI > 50 mL/m2 in either the overall population (p < 0.001) or asymptomatic patients (p = 0.002). Atrial fibrillation (AF), left ventricular mass index (LVMI), MVA, and mean diastolic pressure were factors independently associated with LAVI (all p < 0.05). CONCLUSIONS: A deleterious impact of a high LAVI on outcome was observed in patients with progressive MS. The LAVI was mainly influenced by the presence of AF, the severity of MS, and LVMI in this population.

참고문헌 (27)

  1. Nishimura RA, "2014 AHA", ACC guideline for the management of patients with valvular heart disease : a report of the American College of Cardiology, J Am Coll Cardiol, pp.2014, 63[DOI]
  2. Boon NA, "The medical management of valvar heart disease", Heart, 87, pp.395~400 (2002)
  3. Baumgartner H, "2017 ESC", EACTS Guidelines for the management of valvular heart disease, 2017, pp.38, 2739~2791
  4. Lip GY, "Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach : the euro heart survey on atrial fibrillation", Chest, 137, pp.263~272 (2010)
  5. Levey AS, "National Kidney Foundation practice guidelines for chronic kidney disease : evaluation, classification, and stratification", Ann Intern Med, 139, pp.137~147 (2003)
  6. Lang RM, "Recommendations for cardiac chamber quantification by echocardiography in adults : an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging", J Am Soc Echocardiogr, 28, pp.1~39.e14 (2015)
  7. Sanfilippo AJ, "Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study", Circulation, 82, pp.792~797 (1990)
  8. Rudski LG, "Guidelines for the echocardiographic assessment of the right heart in adults : a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography", J Am Soc Echocardiogr, 23, pp.685~713 (2010)
  9. Hatle L, "Noninvasive assessment of atrioventricular pressure half-time by Doppler ultrasound", Circulation, 60, pp.1096~1104 (1979)
  10. Nunes MC, "Impact of net atrioventricular compliance on clinical outcome in mitral stenosis", Circ Cardiovasc Imaging, 6, pp.1001~1008 (2013)
  11. Flachskampf FA, "Calculation of atrioventricular compliance from the mitral flow profile : analytic and in vitro study", J Am Coll Cardiol, 19, pp.998~1004 (1992)
  12. Zoghbi WA, "Recommendations for noninvasive evaluation of native valvular regurgitation : a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance", J Am Soc Echocardiogr, 30, pp.303~371 (2017)
  13. DeLong ER, "Comparing the areas under two or more correlated receiver operating characteristic curves : a nonparametric approach", Biometrics, 44, pp.837~845 (1988)
  14. Heidbuchel H, "Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation : executive summary", Eur Heart J, 38, pp.2137~2149 (2017)
  15. Takemoto Y, "Usefulness of left atrial volume in predicting first congestive heart failure in patients ≥ 65 years of age with well-preserved left ventricular systolic function", Am J Cardiol, 96, pp.832~836 (2005)
  16. Pritchett AM, "Diastolic dysfunction and left atrial volume : a population-based study", J Am Coll Cardiol, 45, pp.87~92 (2005)
  17. Tamura H, "Increased left atrial volume index predicts a poor prognosis in patients with heart failure", J Card Fail, 17, pp.210~216 (2011)
  18. Yang WI, "Left atrial volume index : a predictor of adverse outcome in patients with hypertrophic cardiomyopathy", J Am Soc Echocardiogr, 22, pp.1338~1343 (2009)
  19. Tani T, "Left atrial volume predicts adverse cardiac and cerebrovascular events in patients with hypertrophic cardiomyopathy", Cardiovasc Ultrasound, 9, pp.34~ (2011)
  20. Møller JE, "Left atrial volume : a powerful predictor of survival after acute myocardial infarction", Circulation, 107, pp.2207~2212 (2003)
  21. Beinart R, "Long-term prognostic significance of left atrial volume in acute myocardial infarction", J Am Coll Cardiol, 44, pp.327~334 (2004)
  22. Messika-Zeitoun D, "Left atrial remodelling in mitral regurgitation--methodologic approach, physiological determinants, and outcome implications : a prospective quantitative Doppler-echocardiographic and electron beam-computed tomographic study", Eur Heart J, 28, pp.1773~1781 (2007)
  23. Le Tourneau T, "Impact of left atrial volume on clinical outcome in organic mitral regurgitation", J Am Coll Cardiol, 56, pp.570~578 (2010)
  24. Ancona R, "Two-dimensional atrial systolic strain imaging predicts atrial fibrillation at 4-year follow-up in asymptomatic rheumatic mitral stenosis", J Am Soc Echocardiogr, 26, pp.270~277 (2013)
  25. Casaclang-Verzosa G, "Structural and functional remodeling of the left atrium : clinical and therapeutic implications for atrial fibrillation", J Am Coll Cardiol, 51, pp.1~11 (2008)
  26. Cho IJ, "Differences in characteristics, left atrial reverse remodeling, and functional outcomes after mitral valve replacement in patients with low-gradient very severe mitral stenosis", J Am Soc Echocardiogr, 29, pp.759~767 (2016)
  27. Nagueh SF, "Recommendations for the evaluation of left ventricular diastolic function by echocardiography : an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging", J Am Soc Echocardiogr, 29, pp.277~314 (2016)

관련 논문AI추천

Prognostic Value of Left Atrial Volume in Patients with Progressive Mitral Stenosis: A Possible Analogy with Left Ventricular Mass in the Setting of Pressure OverloadJun-Bean Park한국심초음파학회 · Journal of Cardiovascular Imaging2019 · 제27권 제2호Predictors of Long-Term Outcomes of Percutaneous Mitral Valvuloplasty in Patients with Rheumatic Mitral Stenosis김다래, 김중선, 남종호, 박동혁, 심지영, 장혁재, 정혜문, 하종원, 홍그루연세대학교의과대학 · Yonsei Medical Journal2018 · 제59권 제2호Associates and Prognosis of Giant Left Atrium; Single Center Experience권혁문, 김종윤, 김효은, 민필기, 박영아, 윤영원, 이병권, 임세중, 정혜문, 최성민, 최의영, 홍범기한국심초음파학회 · Journal of Cardiovascular Imaging2017 · 제25권 제3호승모판협착증 환자에서 뇌경색발생의 예측인자김웅, 김영조, 김형준, 박종선, 신동구, 심봉섭, 이종석, 홍그루영남대학교 의과대학 · Journal of Yeungnam Medical Science2000 · 제17권 제1호Global Left Ventricular Myocardial Work Efficiency in Patients With Severe Rheumatic Mitral Stenosis and Preserved Left Ventricular Ejection FractionAmiliana M Soesanto, Arco J Teske, Bambang B Siswanto, Emir Yonas, Estu Rudiktyo, Maarten J Cramer, Pieter A Doevendans한국심초음파학회 · Journal of Cardiovascular Imaging2023 · 제31권 제4호Cardiac Structural or Functional Changes Associated with CHA2DS2-VASc Scores in Nonvalvular Atrial Fibrillation: A Cross-Sectional Study Using Echocardiography문정근, 박예민, 신미승, 유종욱, 장영우, 정욱진한국심초음파학회 · Journal of Cardiovascular Imaging2018 · 제26권 제3호

이 간행물의 다른 논문 (12건)